BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17121887)

  • 21. [Effect of spleen tyrosine kinase expression re-activation by inhibition of DNA methylation on oncogenesis growth of gastric cancer].
    Ding YB; Xia JG; Chen GY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):523-6. PubMed ID: 17143801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
    Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P
    Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.
    Yang Z; Huo L; Chen H; Ni B; Xiang J; Kang L; Wang L; Peng J; Yuan Y; Wang J
    Med Oncol; 2013; 30(2):586. PubMed ID: 23609194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma].
    Lü GL; Wen JM; Xu JM; Zhang M; Xu RB; Tian BL
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):230-3. PubMed ID: 12882688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
    Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
    Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y; Zhang C; Zhao J; Wang C; Xu Y; Han Z; Jiang G; Guo X; Li R; Bu X; Wu M; Wei L
    Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
    Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
    Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma.
    Hong J; Yuan Y; Wang J; Liao Y; Zou R; Zhu C; Li B; Liang Y; Huang P; Wang Z; Lin W; Zeng Y; Dai JL; Chung RT
    Cancer Res; 2014 Mar; 74(6):1845-56. PubMed ID: 24477596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma].
    Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.